Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Comment by alixx11on Mar 27, 2010 8:52am
329 Views
Post# 16931130

RE: Hanging in......

RE: Hanging in......Let's do a re-cap :

Are they in financial difficulty?
No. And if they raise the SP a bit by Xmas, they can do another, higher-priced financing.

Has management shown themselves to be incompetent?
No, not yet. They're late with news sometimes, but it comes.

Do they have a promising resource?
Yes, we know they do. A million ounces, and an aggressive plan to try and grow it to over 2 million within the next 12-18 months.

Last year when they did the financing, they also issued warrants. They can be exercised before January 2011 at 50 cents, or January 2012 at 75 cents. I'm using that as my rough guide, meaning that I think the SP should be at (or more likely above) those levels at those times. If not, time to re-analyze...

I've been in since Fall 2007, I'm certainly not looking for the exit anytime soon.
Bullboard Posts